
Neuropsychopharmacology (2007) 32, 1358–1369.
Preclinical and clinical studies suggest that the administration of the opioid antagonist naltrexone decreases the intake of ethanol. However, the neuroplastic adaptations in the brain associated to reduction of ethanol consumption remains to be elucidated.
The aim of the study was to identify gene transcription alterations underlying the attenuation of voluntary ethanol intake by administration of naltrexone in rats.
The reduction of ethanol intake induced by naltrexone was associated with a blockade or significant reduction of the changes produced by ethanol in the expression of these genes in key regions related to drug dependence.
These results point to a role for the

Read Full Abstract
Reprint Request E-mail: jmanzanares@umh.es
_____________________________________________________________________